Table 4.
Comparison of IFN-α production.
| Week | Group | Measured value (pg/mL) | Change from baseline (pg/mL) | ||
|---|---|---|---|---|---|
| Mean ± SD | p-value | Mean ± SD | p-value | ||
| 0 | Placebo | 1,275.5 ± 1,025.8 | 0.585 | — | — |
| LG2055 | 1,205.1 ± 701.4 | — | |||
| 4 | Placebo | 878.0 ± 488.8 | 0.796 | −401.1 ± 948.6 | 0.467 |
| LG2055 | 900.0 ± 665.1 | −305.1 ± 847.5 | |||
| 8 | Placebo | 669.5 ± 369.7 | 0.528 | −606.0 ± 989.6 | 0.749 |
| LG2055 | 637.5 ± 321.3 | −567.6 ± 598.9 | |||
| 12 | Placebo | 618.7 ± 271.7 | 0.811 | −656.8 ± 1001.6 | 0.513 |
| LG2055 | 628.5 ± 293.8 | −576.6 ± 627.9 | |||